RIMONDI, Erika
 Distribuzione geografica
Continente #
NA - Nord America 3.439
EU - Europa 902
AS - Asia 390
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
OC - Oceania 1
Totale 4.736
Nazione #
US - Stati Uniti d'America 3.438
CN - Cina 252
IT - Italia 224
PL - Polonia 184
UA - Ucraina 162
DE - Germania 124
TR - Turchia 104
GB - Regno Unito 88
SE - Svezia 44
FI - Finlandia 37
FR - Francia 15
VN - Vietnam 15
RU - Federazione Russa 12
BE - Belgio 7
HK - Hong Kong 7
IN - India 6
IR - Iran 3
IE - Irlanda 2
NL - Olanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BR - Brasile 1
CA - Canada 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
IL - Israele 1
KR - Corea 1
MY - Malesia 1
Totale 4.736
Città #
Fairfield 533
Woodbridge 487
Houston 275
Ashburn 266
Seattle 226
Chandler 218
Ann Arbor 203
Wilmington 196
Jacksonville 189
Cambridge 187
Warsaw 184
Ferrara 122
Beijing 71
Izmir 63
Princeton 59
New York 47
Nanjing 46
San Diego 42
Boardman 31
Shanghai 27
Milan 26
Nanchang 20
Falls Church 19
Los Angeles 16
Shenyang 16
Dearborn 15
Dong Ket 15
Ferrara di Monte Baldo 11
Auburn Hills 9
Hebei 9
Jiaxing 9
San Mateo 9
Tianjin 9
Bremen 8
Changsha 8
London 8
Norwalk 8
Brussels 7
Kunming 7
Mountain View 7
Zhengzhou 7
Aprilia 6
Bologna 6
Hong Kong 6
Jinan 6
Chicago 5
Ningbo 5
Orange 5
Tappahannock 5
Washington 5
Guangzhou 4
Leawood 4
Rome 4
Acton 3
Addison 3
Bari 3
Bentivoglio 3
Des Moines 3
Indiana 3
Meerut 3
Philadelphia 3
Redmond 3
Redwood City 3
Verona 3
Andover 2
Ardabil 2
Augusta 2
Bassano Del Grappa 2
Bucine 2
Forlì 2
Haikou 2
Hefei 2
Kilburn 2
Monmouth Junction 2
New Delhi 2
Padova 2
San Francisco 2
Wandsworth 2
Azzano Decimo 1
Barcelona 1
Brescia 1
Canberra 1
Catanzaro 1
Changchun 1
Chieri 1
Copertino 1
Groningen 1
Helsinki 1
Hounslow 1
Islington 1
Krimpen Aan Den Ijssel 1
Kuantan 1
La Canada Flintridge 1
Lanzhou 1
Lappeenranta 1
Lviv 1
Montpellier 1
Odesa 1
Paris 1
Prescot 1
Totale 3.859
Nome #
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 164
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 152
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 152
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 149
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 146
miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment 130
Nutlin-3 upregulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feed-back anti-apoptotic mechanism 123
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment 119
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 119
TRAIL and osteoprotegerin: a role in endothelial physiopathology? 114
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 113
Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL 111
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients 108
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 105
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 103
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions. 102
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 101
Soluble TRAIL does not impair the anti-osteoclastic activity of osteoprotegerin: Letter to the editor 100
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation 99
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 98
Human Colostrum and Breast Milk Contain High Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL). 96
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1. 95
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 95
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors 93
null 92
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 92
null 90
null 90
null 88
null 86
Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Show a Long-term Stability in the Breast Milk of Mothers of Preterm Infants 85
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 85
Factors Predictive of Double Anterior Chamber Formation Following Deep Anterior Lamellar Keratoplasty 85
TRAIL activates a caspase 9/7-dependent pathway in caspase 8/10-defective SK-N-SH neuroblastoma cells with two functional end-points: induction of apoptosis and PGE2 release. 84
null 83
Effects of intermittent pneumatic compression treatment on clinical outcomes and biochemical markers in patients at low mobility with lower limb edema 82
New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: recent advances 81
A novel endovenous scaffold for the treatment of chronic venous obstruction in a porcine model: Histological and ultrastructural assessment 78
Lower maternal serum tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in early preeclampsia. A retrospective study 77
null 76
Activation of the p53 pathway down-regulates the osteoprotegerin (OPG) expression and release by vascular endothelial cells. 76
null 69
null 55
Role of vitamin D in the pathogenesis of atheromatosis 54
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 52
null 44
null 42
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 29
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 25
Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids 25
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 23
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL) 23
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 22
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 21
Ultrastructural Alterations of Grafted Corneal Buttons: The Anatomic Basis for Stromal Peeling Along a Natural Plane of Separation 20
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 19
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 18
MitoQ is able to modulate apoptosis and inflammation 16
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 14
The role of the mTOR pathway in diabetic retinopathy 13
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF 13
Tumor necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 12
Receptor activator of nuclear factor kappa B ligand (RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts 11
Human collecting lymphatic glycocalyx identification by electron microscopy and immunohistochemistry. 8
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 8
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 7
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 6
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 5
Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study 3
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 3
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions 1
Totale 4.878
Categoria #
all - tutte 19.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.129


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019389 0 0 0 0 0 0 0 0 0 0 166 223
2019/20201.211 151 42 50 184 84 122 121 134 114 120 48 41
2020/2021918 45 66 27 118 89 118 57 101 39 133 81 44
2021/2022615 28 54 25 21 56 48 56 37 21 55 60 154
2022/2023523 58 32 23 59 77 74 34 46 71 2 29 18
2023/2024255 33 39 13 12 20 57 16 41 1 23 0 0
Totale 4.878